Clinical predictors of response to treatment in catatonia

General Hospital Psychiatry

Volumn 34, Issue 3, 2012, Pages 312-316

  Narayanaswamy, Janardhanan C ^a   Tibrewal, Prashant ^a   Zutshi, Amit ^a   Srinivasaraju, Ravindra ^a   Math, Suresh Bada ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Catatonia; Lorazepam

Indexed keywords

LORAZEPAM;

ADOLESCENT; ADULT; AGED; ARTICLE; AUDITORY HALLUCINATION; CATATONIA; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTISM; OUTCOME ASSESSMENT; PREDICTION; RURAL POPULATION;

ADOLESCENT; ADULT; AGED; CATATONIA; FEMALE; FORECASTING; HUMANS; HYPNOTICS AND SEDATIVES; INDIA; LORAZEPAM; MALE; MEDICAL AUDIT; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860376378     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2012.01.011     Document Type: Article

References (19)

1. Northoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci 2002, 25:555-577. [discussion 578-604].
2. Taylor M.A., Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003, 160:1233-1241.
3. Ungvari G.S., Kau L.S., Wai-Kwong T., Shing N.F. The pharmacological treatment of catatonia: an overview. Eur Arch Psychiatry Clin Neurosci 2001, 251(Suppl 1):I31-I34.
4. Hawkins J.M., Archer K.J., Strakowski S.M., Keck P.E. Somatic treatment of catatonia. Int J Psychiatry Med 1995, 25:345-369.
5. Bush G., Fink M., Petrides G., Dowling F., Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996, 93:137-143.
6. Casey D.A. Intravenous lorazepam in psychogenic catatonia. J Clin Psychopharmacol 1987, 7:360-361.
7. Huang T.L. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005, 59:52-55.
8. Rosebush P.I., Hildebrand A.M., Furlong B.G., Mazurek M.F. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990, 51:357-362.
9. Pommepuy N., Januel D. Catatonia: resurgence of a concept. A review of the international literature. Encephale 2002, 28:481-492.
10. Hung Y.Y., Huang T.L. Lorazepam and diazepam rapidly relieve catatonic features in major depression. Clin Neuropharmacol 2006, 29:144-147.
11. Falkai P., Wobrock T., Lieberman J., Glenthoj B., Gattaz W.F., Moller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: acute treatment of schizophrenia. World J Biol Psychiatry 2005, 6:132-191.
12. Girish K., Gill N.S. Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian J Psychiatry 2003, 45:21-25.
13. Tibrewal P., Narayanaswamy J., Zutshi A., Srinivasaraju R., Math S.B. Response rate of lorazepam in catatonia: a developing country's perspective. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1520-1522.
14. Mellor C.S. First rank symptoms of schizophrenia. I. The frequency in schizophrenics on admission to hospital. II. Differences between individual first rank symptoms. Br J Psychiatry 1970, 117:15-23.
15. Ungvari G.S., Chiu H.F., Chow L.Y., Lau B.S., Tang W.K. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl) 1999, 142:393-398.
16. Wunderink A., Nienhuis F.J., Sytema S., Wiersma D. Treatment delay and response rate in first episode psychosis. Acta Psychiatr Scand 2006, 113:332-339.
17. Perkins D., Lieberman J., Gu H., Tohen M., McEvoy J., Green A., et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 2004, 185:18-24.
18. de Diego-Adelino J., Portella M.J., Puigdemont D., Perez-Egea R., Alvarez E., Perez V. A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes. J Affect Disord 2010, 120:221-225.
19. Altamura A.C., Dell'osso B., D'Urso N., Russo M., Fumagalli S., Mundo E. Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder. CNS Spectr 2008, 13:415-422.